COLESTYRAMINE ( DrugBank: Colestyramine )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 254 | ポルフィリン症 | 1 |
254. ポルフィリン症
臨床試験数 : 70 / 薬物数 : 54 - (DrugBank : 19) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 35
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2007-002863-28-GB (EUCTR) | 26/09/2007 | 15/08/2007 | Investigation into the use of colestyramine as a therapy for patients with erythropoietic protoporphyria - EPP001 | Investigation into the use of colestyramine as a therapy for patients with erythropoietic protoporphyria - EPP001 | Erythropoietic protoporphyria (EPP) MedDRA version: 9.1;Level: LLT;Classification code 10015289;Term: Erythropoietic protoporphyria | Trade Name: Questran Product Name: Questran INN or Proposed INN: COLESTYRAMINE | Guy's & St Thomas' NHS Foundation Trust | NULL | Not Recruiting | Female: yes Male: yes | 21 | Phase 4 | United Kingdom |